Hepatitis B: all 1,662 studies

Page 3 of 17. Open to participants first (192), then studies with results posted, then the rest; newest registration first within each.

• A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B InfectionTerminatedNCT04820686Phase 2Results posted
• A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus InfectionTerminatedNCT04781647Phase 2Results posted
• First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBVCompletedNCT04778904Phase 1/2Results posted
• Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT04749368Phase 2Results posted
• Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB)CompletedNCT04676724Phase 2Results posted
• A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus InfectionCompletedNCT04667104Phase 2Results posted
• A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus InfectionCompletedNCT04585789Phase 2Results posted
• A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis BCompletedNCT04544956Phase 2Results posted
• A Bridging Study: Comparing Two Lots of Sci-B-Vac™ and Engerix-B in Healthy AdultsCompletedNCT04531098Phase 3Results posted
• Study of VIR-2218 in Patients With Chronic Hepatitis B in Mainland ChinaCompletedNCT04507269Phase 2Results posted
• A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013)CompletedNCT04490499Phase 3Results posted
• Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD)TerminatedNCT04465916Phase 2Results posted
• HepB-CpG Series for Healthcare Workers Who Are Hepatitis B Vaccine NonrespondersCompletedNCT04456504Phase 4Results posted
• A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse Transcriptase InhibitorsTerminatedNCT04454567Phase 2Results posted
• A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB)CompletedNCT04449029Phase 2Results posted
• Study of VIR-3434 in Healthy Volunteers and Patients With Chronic Hepatitis B Virus InfectionCompletedNCT04423393Phase 1Results posted
• Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus InfectionCompletedNCT04412863Phase 2Results posted
• A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus InfectionTerminatedNCT04398134Phase 2Results posted
• Prevalence of HBV in Pregnant Women Attending Antenatal Care in TanzaniaCompletedNCT04325542Not applicableResults posted
• First in Human Study of ChAdOx1-HBV in Healthy Participants and Participants With Chronic hepB InfectionCompletedNCT04297917Phase 1Results posted
• The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B ScreeningCompletedNCT04240678Not applicableResults posted
• Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B®CompletedNCT04209400Phase 3Results posted
• B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-BCompletedNCT04193189Phase 3Results posted
• A Study to Qualify an In-house Reference Standard Batch of Sci-B-Vac™CompletedNCT04179786Phase 4Results posted
• A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus InfectionCompletedNCT04129554Phase 2Results posted
• Chronic HBV Management for Asian AmericanCompletedNCT04082338Not applicableResults posted
• A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus InfectionCompletedNCT03982186Phase 2Results posted
• HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing HemodialysisCompletedNCT03934736Phase 1Results posted
• Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis BCompletedNCT03905655Phase 2Results posted
• Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid TumorsTerminatedNCT03887702Phase 3Results posted
• B/F/TAF Switch Study for HIV-HBV CoinfectionCompletedNCT03797014Phase 4Results posted
• A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B PatientsTerminatedNCT03780543Phase 2Results posted
• A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus InfectionTerminatedNCT03762681Phase 1Results posted
• HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)CompletedNCT03685708Phase 2Results posted
• Study of VIR-2218 in Healthy Subjects and Patients With Chronic Hepatitis BCompletedNCT03672188Phase 1/2Results posted
• Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on TreatmentCompletedNCT03615066Phase 2Results posted
• A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV)CompletedNCT03577171Phase 2Results posted
• A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B InfectionCompletedNCT03576066Phase 2Results posted
• A Double-Blind Single-Ascending Dose (SAD) and Multiple-Ascending Dose (MAD) Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7049389 in Healthy Chinese ParticipantsCompletedNCT03570658Phase 1Results posted
• Arresting Vertical Transmission of Hepatitis B VirusCompletedNCT03567382Phase 4Results posted
• Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected AdultsCompletedNCT03547908Phase 3Results posted
• A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis DCompletedNCT03546621Phase 2Results posted
• Mild Hypothermia and Acute Kidney Injury in Liver TransplantationTerminatedNCT03534141Not applicableResults posted
• Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis BCompletedNCT03491553Phase 2Results posted
• Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)CompletedNCT03471624Phase 4Results posted
• Study to Evaluate the Safety and Antiviral Activity of Inarigivir Soproxil (Formerly: GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB)TerminatedNCT03434353Phase 2Results posted
• Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional VaccinesCompletedNCT03410953Phase 4Results posted
• Lot-to-lot Consistency of Sci-B-Vac™ in AdultsCompletedNCT03408730Phase 3Results posted
• Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in AdultsCompletedNCT03393754Phase 3Results posted
• Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV)CompletedNCT03365947Phase 1/2Results posted
• An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus InfectionCompletedNCT03361956Phase 2Results posted
• Immunogenicity of Hepatitis B Vaccination in HIV-infected AdultsCompletedNCT03316807Phase 4Results posted
• Ledipasvir/Sofosbuvir for Hepatitis B Virus InfectionCompletedNCT03312023Phase 2Results posted
• A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis BCompletedNCT03258710Phase 4Results posted
• Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)CompletedNCT03180619Phase 2Results posted
• A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical SettingCompletedNCT03083821Phase 1Results posted
• The Relationship Between Vitamin D and Hepatitis B Virus ReplicationCompletedNCT03068767Not applicableResults posted
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis BCompletedNCT03038113Phase 1Results posted
• A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) SubjectsCompletedNCT03020745Phase 2Results posted
• Immunogenicity of Hepatitis B Vaccination in Methadone Maintenance Treatment PatientsCompletedNCT02991599Phase 4Results posted
• A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in CanadaCompletedNCT02985450Results posted
• Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV InfectionCompletedNCT02981602Phase 2Results posted
• Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically SuppressedCompletedNCT02979613Phase 3Results posted
• A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )CompletedNCT02964910Phase 4Results posted
• Immunogenicity of Hepatitis B Vaccination in Hemodialysis PatientsCompletedNCT02963714Phase 4Results posted
• Immunogenicity of Hepatitis B Vaccination Among Drug UsersCompletedNCT02959775Phase 4Results posted
• A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531CompletedNCT02956850Phase 1Results posted
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7049389 in Healthy Volunteers and Chronic Hepatitis B Virus (HBV) Infected ParticipantsCompletedNCT02952924Phase 1Results posted
• Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-BCompletedNCT02901951Phase 4Results posted
• Myrcludex B in Combination With Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients With Chronic Viral Hepatitis B With Delta-agentCompletedNCT02888106Phase 2Results posted
• Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis BCompletedNCT02881008Phase 1/2Results posted
• Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver TransplantCompletedNCT02862548Phase 2Results posted
• Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis BCompletedNCT02862106Phase 2Results posted
• A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in RussiaCompletedNCT02858440Phase 3Results posted
• Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-deliveryCompletedNCT02853929Phase 4Results posted
• Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China)CompletedNCT02836249Phase 3Results posted
• Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China)CompletedNCT02836236Phase 3Results posted
• A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During InfancyCompletedNCT02798952Phase 4Results posted
• A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)TerminatedNCT02797522Phase 1Results posted
• A Study of Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access ProgramCompletedNCT02791269Phase 4Results posted
• Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)CompletedNCT02759354Phase 3Results posted
• Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) InfectionTerminatedNCT02738008Phase 2Results posted
• Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis BCompletedNCT02726789Phase 2Results posted
• First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy SubjectsCompletedNCT02647281Phase 1Results posted
• A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus InfectionTerminatedNCT02604212Phase 2Results posted
• A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) InfectionTerminatedNCT02604199Phase 2Results posted
• Study to Evaluate the Safety, Tolerability, and Efficacy of Vesatolimod in Combination With Tenofovir Disoproxil Fumarate (TDF) in Adults With Chronic Hepatitis B (CHB) Infection Who Are Currently Not Being TreatedCompletedNCT02579382Phase 2Results posted
• Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)TerminatedNCT02577029Phase 2Results posted
• Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-respondersCompletedNCT02540538Phase 1Results posted
• Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis BCompletedNCT02496897Phase 1Results posted
• Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus InfectionTerminatedNCT02479880Phase 4Results posted
• FibroTouch Non-invasive Evaluation of Liver Fibrosis and CirrhosisCompletedNCT02476695Results posted
• Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B VirusTerminatedNCT02452528Phase 2Results posted
• Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-deliveryCompletedNCT02422264Phase 4Results posted
• A Comparative Trial of Improving Care for Underserved Asian Americans Infected With HBVCompletedNCT02421666Not applicableResults posted
• Add-on Peginterferon Following Nucleos(t)Ide Analogue TreatmentCompletedNCT02364336Phase 2Results posted
• Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Adults With Normal Hepatic Function and Adults With Severe Hepatic ImpairmentCompletedNCT02296853Phase 1Results posted
• A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant PhaseCompletedNCT02263079Phase 3Results posted
• Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated CirrhosisCompletedNCT02224456Phase 4Results posted
• A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy AdultsCompletedNCT02203357Phase 4Results posted

← Hepatitis B overview